FL H1431 | 2024 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Republican 2-0)
Status: Failed on March 8 2024 - 100% progression
Action: 2024-03-08 - Died in Appropriations Committee
Text: Latest bill text (Introduced) [PDF]
Spectrum: Partisan Bill (Republican 2-0)
Status: Failed on March 8 2024 - 100% progression
Action: 2024-03-08 - Died in Appropriations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires prescription drug manufacturer permitholders to annually report certain international price data to AHCA; provides for administrative enforcement via specified fine & permit suspension; requires AHCA to contract with entity to designate reference price source countries & establish reference prices for prescription drugs based on certain criteria; requires agency contractor to weigh reference price benchmark value of such countries in two or more tiers, using specified criteria; requires agency contractor to analyze specified data to compare prices among source countries using specified exchange rate source; requires agency contractor to establish reference price for prescribed drugs or products; requires agency contractor to provide reference prices by specified date each year; requires AHCA to publish prices online within specified time; requires pharmacies to charge no more than reference price for cash-paying patients; requires certain health insurers to provide reimbursement for certain prescription drugs no higher than reference price; requires health insurers to use certain savings to offset certain payer costs; requires each health insurer to document anticipated savings & premium reductions in rate filings following availability of reference prices; requires each health insurer to assess actuarial effect of reference pricing program for each insurer product for each plan year; requires each health insurer to submit annual report on assessed effect of such program to OIR or AHCA; requires OIR & AHCA to submit joint report to Governor & Legislature; requires every health maintenance organization to comply with provisions of specified section.
Title
International Drug Reference Pricing
Sponsors
Roll Calls
2024-01-22 - House - House Select Committee on Health Innovation (Y: 13 N: 2 NV: 0 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-03-08 | House | Died in Appropriations Committee |
| 2024-01-23 | House | Now in Appropriations Committee |
| 2024-01-23 | House | Reported out of Select Committee on Health Innovation |
| 2024-01-22 | House | Favorable by Select Committee on Health Innovation |
| 2024-01-18 | House | Added to Select Committee on Health Innovation agenda |
| 2024-01-13 | House | Now in Select Committee on Health Innovation |
| 2024-01-13 | House | Referred to Health & Human Services Committee |
| 2024-01-13 | House | Referred to Appropriations Committee |
| 2024-01-13 | House | Referred to Select Committee on Health Innovation |
| 2024-01-09 | House | 1st Reading (Original Filed Version) |
| 2024-01-06 | House | Filed |
Same As/Similar To
S1750 (Similar To) 2024-03-08 - Died in Health Policy
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| 465 | 0244 | Amended Code | See Bill Text | |
| 499 | 044 | Amended Code | See Bill Text | |
| 627 | 6044 | Amended Code | See Bill Text | |
| 641 | 30 | Amended Code | See Bill Text |
